These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1298037)

  • 1. [Intra-nasal calcitonin for the prevention of postmenopausal osteoporosis].
    Meunier PJ
    Rev Med Univ Navarra; 1992; 37(4):200-4. PubMed ID: 1298037
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Osteoporos Int; 1993; 3 Suppl 1():208-10. PubMed ID: 8461563
    [No Abstract]   [Full Text] [Related]  

  • 3. Nasal calcitonin for treatment of established osteoporosis.
    Overgaard K; Riis BJ; Christiansen C; Pødenphant J; Johansen JS
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):435-42. PubMed ID: 2688995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
    J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using miacalcic nasal spray 200 UI in the treatment of osteoporosis in women of 40-70 years of age during menopause according to data of the center "Osteoporosis" in Khaskovo city].
    Staĭkova N; Filipov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():10-4. PubMed ID: 15323311
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M
    Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different doses of nasal salmon calcitonin on bone mass.
    Thamsborg G; Storm TL; Sykulski R; Brinch E; Nielsen HK; Sørensen OH
    Calcif Tissue Int; 1991 May; 48(5):302-7. PubMed ID: 2054714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin.
    Silverman SL
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):273-84. PubMed ID: 12699303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study.
    Pontiroli AE; Pajetta E; Calderara A; Alberetto M; Pozza G; Manganelli V; Resmini G; Tessari L; Maresca V
    J Endocrinol Invest; 1991 Jan; 14(1):47-51. PubMed ID: 1646250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.
    Huusko TM; Karppi P; Kautiainen H; Suominen H; Avikainen V; Sulkava R
    Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic effect of nasal salmon calcitonin during the early post-fracture period of the distal radius fracture.
    Karponis A; Rizou S; Pallis D; Zafeiris CP; Georgiou DF; Galanos A; Giannoulis F; Lyritis GP
    J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):186-9. PubMed ID: 26032211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
    Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.